effects [qlco]
Hormone replacement therapy [topp]
Fibrinolysis [phsf]
postmenopausal [tmco]
Women [popg]
Plasma [bdsu]
Plasminogen Activator Inhibitor Type 1 [aapp, bacs]
Essential [qlco]
Inhibitor [qlco]
Fibrinolysis [phsf]
Humans [humn]
Women [popg]
Menopause [phsf]
Contribute [acty]
Cardiovascular disease [dsyn]
Study [mnob]
effects [qlco]
Hormone replacement therapy [topp]
Plasminogen Activator Inhibitor Type 1 [aapp, bacs]
Levels [qlco]
Methods [inpr]
randomized [resa]
Cross-Over Study [resa]
investigated [ftcn]
effects [qlco]
Oral [spco]
Conjugated estrogen [horm, phsu, strd]
mg% [qnco]
postmenopausal [tmco]
Women [popg]
Transdermal [ftcn]
Estradiol [horm, phsu, strd]
mg% [qnco]
postmenopausal [tmco]
Women [popg]
Alone [qnco]
Combination [qlco]
medroxyprogesterone acetate [horm, phsu, strd]
2 5 [qnco]
mg% [qnco]
Daily [tmco]
Plasma [bdsu]
Plasminogen Activator Inhibitor Type 1 [aapp, bacs]
antigen levels [lbpr]
degradation [ftcn]
Products [enty]
Cross Linked [npop]
Fibrin [aapp, bacs, phsu]
D-dimer [aapp, bacs]
Measured [qlco]
Index [inpr]
Fibrinolysis [phsf]
Plasminogen Activator Inhibitor Type 1 [aapp, bacs]
Levels [qlco]
D-dimer [aapp, bacs]
Levels [qlco]
baseline [bodm]
R- [spco]
P NOS [aapp, imft]
Conjugated estrogen [horm, phsu, strd]
Alone [qnco]
Combination [qlco]
medroxyprogesterone acetate [horm, phsu, strd]
Reduced [qlco]
SD [fndg]
Plasma [bdsu]
Plasminogen Activator Inhibitor Type 1 [aapp, bacs]
milliliter [qnco]
milliliter [qnco]
P NOS [aapp, imft]
milliliter [qnco]
milliliter [qnco]
P NOS [aapp, imft]
Inverse [qlco]
Correlation [qlco]
Pretreatment [sbst]
Plasminogen Activator Inhibitor Type 1 [aapp, bacs]
Levels [qlco]
Degree [qlco]
reduction [npop]
Levels [qlco]
therapy [ftcn]
R- [spco]
P NOS [aapp, imft]
Conjugated estrogen [horm, phsu, strd]
R- [spco]
P NOS [aapp, imft]
Combined therapy [topp]
Degree [qlco]
reduction [npop]
Plasminogen Activator Inhibitor Type 1 [aapp, bacs]
Levels [qlco]
increases [ftcn]
D-dimer [aapp, bacs]
Levels [qlco]
Conjugated estrogen [horm, phsu, strd]
GIVEN [cnce]
Alone [qnco]
R- [spco]
P NOS [aapp, imft]
Combined therapy [topp]
Hormone [horm]
GIVEN [cnce]
R- [spco]
P NOS [aapp, imft]
Transdermal [ftcn]
Estradiol [horm, phsu, strd]
Plasminogen Activator Inhibitor Type 1 [aapp, bacs]
Levels [qlco]
baseline [bodm]
Values [qlco]
Conclusions [idcn]
Conjugated estrogen [horm, phsu, strd]
Alone [qnco]
Combined [qlco]
progestin therapy [topp]
Reduced [qlco]
Plasminogen Activator Inhibitor Type 1 [aapp, bacs]
Levels [qlco]
Approximately [qlco]
Percent [qnco]
postmenopausal [tmco]
Women [popg]
Enhanced [acty]
Systemic [ftcn]
Fibrinolysis [phsf]
findings [ftcn]
Hormone replacement therapy [topp]
coronary artery disease [dsyn]
Massachusetts [geoa]
Society, Medical [pros]
